The Health Sciences Authority (HSA) of Singapore and the Malaysian Ministry of Health have signed on to a memorandum of understanding in which both agencies will collaborate on regulatory science, enforcement efforts, post market vigilance and quality system issues impacting their respective markets.

Malaysian and Singaporean authorities will cooperate by exchanging assessment reports regarding medical product registrations, working toward supporting market entry of products in both countries. The HSA and Ministry of Health also plan to share data on complementary medicinal products, as well as setting up a joint system to monitor adverse signals for these types of products.

Setting up formal intelligence networks for post-market surveillance as well as monitoring counterfeiting are also planned by the HSA and Ministry of Health.